In animal models of metabolic inflammation, T2DM, or nonalcoholic steatohepatitis, increased LCN2 expression promotes inflammation through the recruitment of inflammatory cells and induction of proinflammatory cytokines (Moschen et al., 2017). Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.